PHP345 - INNOVATIVE PAYMENT MODELS FOR BREAKTHROUGH THERAPIES

Bioinnovation Enterprise: An engine driving breakthrough therapies.

Biological advances have radically expanded our insights into the underpinnings of health and disease. New knowledge has formed the substrate for translation-expedited in turn by the biotechnology and pharmaceutical industry into novel therapeutic solutions impacting the management of patients and populations. Indeed, this Bioinnovation Enterprise has become the dominant growth sector in drug d...

Innovative Schooner Appliances Deliver Breakthrough Performance for Data-Intensive Applications

High-volume Web and transactional applications are putting intense pressure on today’s data centers. Explosive growth and unpredictable peak loads combine with high user expectations to place extreme demands on traditional server and storage systems. More compute capacity alone is not the answer. IT organizations also need to provide faster access to multi-terabyte data sets, and they need to p...

Crizotinib: A Breakthrough for Targeted Therapies in Lung Cancer

J Adv Pract Oncol 2012;3:267–272 Lung cancer is the leading cause of cancer-related mortality in the United States, with approximately 226,160 new cases of lung and bronchial cancer predicted to be diagnosed in 2012, along with approximately 160,340 deaths due to the disease (Siegel, Naishadham, & Jemal, 2012). Worldwide, approximately 1.6 million new cases of lung cancer are diagnosed every ye...

Medical self-defense, prohibited experimental therapies, and payment for organs.

Why Stark , Why Now ? Suggestions to Improve the Stark Law to Encourage Innovative Payment Models